These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 8732362

  • 21. A comparative study of the post-antifungal effect (PAFE) of amphotericin B, triazoles and echinocandins on Aspergillus fumigatus and Candida albicans.
    Manavathu EK, Ramesh MS, Baskaran I, Ganesan LT, Chandrasekar PH.
    J Antimicrob Chemother; 2004 Feb; 53(2):386-9. PubMed ID: 14729762
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Suppression of ATP in Candida albicans by imidazole and derivative antifungal agents.
    Odds FC, Cheesman SL, Abbott AB.
    Sabouraudia; 1985 Dec; 23(6):415-24. PubMed ID: 3913012
    [Abstract] [Full Text] [Related]

  • 24. [Identification and antifungal susceptibility of Candida spp isolated from invasive mycoses. Influence of growth inhibition percentage to determine minimal inhibitory concentration].
    Alvarado D, Díaz MC, Silva V.
    Rev Med Chil; 2002 Apr; 130(4):416-23. PubMed ID: 12090107
    [Abstract] [Full Text] [Related]

  • 25. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
    Mallié M, Bastide JM, Blancard A, Bonnin A, Bretagne S, Cambon M, Chandenier J, Chauveau V, Couprie B, Datry A, Feuilhade M, Grillot R, Guiguen C, Lavarde V, Letscher V, Linas MD, Michel A, Morin O, Paugam A, Piens MA, Raberin H, Tissot E, Toubas D, Wade A.
    Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
    [Abstract] [Full Text] [Related]

  • 26. Susceptibility to 5-fluorocytosine, miconazole and amphotericin B of Candida albicans strains isolated from the throat of non-AIDS patients.
    Paniagua GL, Monroy E, Negrete E, Vaca S.
    Rev Latinoam Microbiol; 2002 Apr; 44(2):65-8. PubMed ID: 17063773
    [Abstract] [Full Text] [Related]

  • 27. A new in-vitro kinetic model to study the pharmacodynamics of antifungal agents: inhibition of the fungicidal activity of amphotericin B against Candida albicans by voriconazole.
    Lignell A, Johansson A, Löwdin E, Cars O, Sjölin J.
    Clin Microbiol Infect; 2007 Jun; 13(6):613-9. PubMed ID: 17378925
    [Abstract] [Full Text] [Related]

  • 28. Intrinsic in vitro susceptibility of primary clinical isolates of Aspergillus fumigatus, Aspergillus terreus, Aspergillus nidulans, Candida albicans and Candida lusitaniae against amphotericin B.
    Singh J, Rimek D, Kappe R.
    Mycoses; 2006 Mar; 49(2):96-103. PubMed ID: 16466441
    [Abstract] [Full Text] [Related]

  • 29. Anti-Candida effects of estragole in combination with ketoconazole or amphotericin B.
    Shin S, Pyun MS.
    Phytother Res; 2004 Oct; 18(10):827-30. PubMed ID: 15551395
    [Abstract] [Full Text] [Related]

  • 30. Comparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colorimetric method based on reduction of a soluble tetrazolium salt, 2,3-bis [2-methoxy-4-nitro-5-[(sulfenylamino) carbonyl]-2H-tetrazolium-hydroxide], for antifungal susceptibility testing of Aspergillus species.
    Meletiadis J, Mouton JW, Meis JF, Bouman BA, Donnelly PJ, Verweij PE, EUROFUNG Network.
    J Clin Microbiol; 2001 Dec; 39(12):4256-63. PubMed ID: 11724829
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Effects of the combination of ketoconazole and calcium channel antagonists against Candida albicans in vitro.
    Krajewska-Kułak E, Niczyporuk W.
    Arzneimittelforschung; 1993 Jul; 43(7):782-3. PubMed ID: 8369013
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effects of the combination of ketoconazole and calmodulin inhibitors against Candida albicans in vitro. Short communication.
    Krajewska-Kułak E, Niczyporuk W.
    Arzneimittelforschung; 1993 Sep; 43(9):1018-9. PubMed ID: 8240451
    [Abstract] [Full Text] [Related]

  • 40. Synthesis, morphology and antifungal activity of nano-particulated amphotericin-B, ketoconazole and thymoquinone against Candida albicans yeasts and Candida biofilm.
    Randhawa MA, Gondal MA, Al-Zahrani AH, Rashid SG, Ali A.
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2015 Sep; 50(2):119-24. PubMed ID: 25560257
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.